Hazard Ratio in Clinical Trials
Open Access
- 1 August 2004
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (8), 2787-2792
- https://doi.org/10.1128/aac.48.8.2787-2792.2004
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Analysis of Survival DataPublished by Taylor & Francis Ltd ,2018
- A Randomized, Placebo-Controlled Comparison of Oral Valacyclovir and Acyclovir in Immunocompetent Patients With Recurrent Genital Herpes InfectionsArchives of Dermatology, 1998
- Acyclovir with and without Prednisone for the Treatment of Herpes ZosterAnnals of Internal Medicine, 1996
- A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.1996
- A Large-Scale, Placebo-Controlled, Dose-Ranging Trial of Peroral Valaciclovir for Episodic Treatment of Recurrent Herpes GenitalisArchives of Internal Medicine, 1996
- Oral Acyclovir Therapy Accelerates Pain Resolution in Patients with Herpes Zoster: A Meta-analysis of Placebo-Controlled TrialsClinical Infectious Diseases, 1996
- Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 1995
- Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysisJournal of Medical Virology, 1993
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984
- Evaluating the Yield of Medical TestsJAMA, 1982